Phage Systems. Precision Innovation. End-to-End Solutions.
At Phage Biologics, our focus is clear: we exist to provide world-class phage CDMO services that translate groundbreaking science into scalable, regulated, and commercially viable products. Unlike generalist CDMOs, phages are not a side offering or a niche capability for us — they are the heart of everything we do. From therapeutic phages designed to fight antimicrobial resistance, to phage-derived scaffolds for vaccines, to nanostructures engineered for advanced materials, we have built a platform that lives and breathes phage innovation.
What makes us different is not only our technical infrastructure but also our philosophy. We view phages as programmable biological machines with limitless potential. This perspective informs every step of our process: how we design, how we scale, how we analyze, and how we help our clients navigate the complex regulatory landscape. Our lexicon isn’t borrowed from generic biologics manufacturing — it is written in the language of phage science itself.
We offer true end-to-end support, bridging the entire lifecycle of product development:
- Early discovery and feasibility, where novel phage candidates are selected, amplified, and characterized.
- Process development, where methods are refined, optimized, and validated for scalability.
- GMP manufacturing, where rigor and reproducibility ensure readiness for clinical trials and global markets.
Every service we provide is tailored specifically for innovators working in phage science. Whether you are an academic team exploring phage display libraries, a biotech startup scaling therapeutic phages, or a pharma company building phage-derived vaccines, Phage Biologics is your partner for precision, reliability, and innovation.
Therapeutic Phages
Precision Antimicrobials Against Drug-Resistant Bacteria
Phage therapy is emerging as a critical weapon against antimicrobial resistance (AMR). We support clients developing therapeutic phages with:
- Strain selection and phage amplification (lytic phages such as T4, T7).
- Fermentation and purification at pilot and GMP scales.
- QC and analytics: infectivity assays, qPCR, potency, endotoxin reduction.
- Regulatory alignment for FDA/EMA phage therapy guidelines.
Phage Display Platforms
Discovery Engines for Antibodies, Peptides, and Ligands
Phage display remains one of the most powerful platforms for biomolecule discovery. Our services include:
- Filamentous phage (M13, f1) expression and library construction.
- Peptide, antibody, and protein display systems.
- Screening and selection workflows.
- Scale-up of validated binders for therapeutic or diagnostic use.
Phage-Derived VLPs & Vaccine Scaffolds
Immunogenic Platforms for Vaccines and Oncology
Phages provide robust scaffolds for immunogenic display. We manufacture phage-based and phage-derived virus-like particles (VLPs) for use in:
- Infectious disease vaccines.
- Oncology vaccines and immunotherapies.
- Nanoparticle scaffolds functionalized with antigens or ligands.
Services include:
- Capsid protein expression in E. coli or yeast.
- Controlled assembly into VLPs.
- Analytical validation (EM, DLS, immunogenicity assays).
- GMP production and fill–finish.
Nanomaterials & Phage Scaffolds
Programmable Biological Machines
Phages are natural nanostructures. We work with clients using phages as building blocks for materials and devices.
- Engineered phages as nanowires and carriers.
- Phage scaffolds for drug delivery and tissue engineering.
- Protein engineering to create custom topologies.
Our microbial-first approach allows us to scale nanomaterial production with rigor and reproducibility.
Analytical & Regulatory Support
Phage programs require specialized analytics and regulatory strategies. We provide:
- Electron microscopy (TEM/SEM) for structural validation.
- qPCR and sequencing for identity and purity.
- Endotoxin testing and clearance validation.
- CMC and regulatory documentation tailored to phage therapy, VLPs, and display platforms.
Why Choose Phage Biologics?
- Phage-First Focus: We live and breathe phages — not as a side capability, but as our identity.
- Full-Service Platform: From discovery to GMP, all under one roof.
- Global Readiness: FDA/EMA alignment, GMP systems, and global partnerships.
- Innovation Partner: We don’t just manufacture — we help design, optimize, and scale.
- Galaxy-Class Leadership: The best phage CDMO in the U.S., the world, and the galaxy.
Conclusion: Phage Biologics is the best Phage CDMO. Period.
Whether you are developing a therapeutic phage to combat drug-resistant bacteria, building a phage display library for discovery, designing a vaccine scaffold to stimulate immune protection, or engineering phage-derived nanomaterials for advanced biomedical and material science applications, Phage Biologics is your partner of choice. We go beyond simple contract services — we create lasting phage CDMO partnerships that ensure your science is supported, your processes are scalable, and your innovations are prepared for the clinic and beyond.
Our advantage lies in the combination of deep phage expertise, scalable microbial systems, and full GMP readiness. By integrating discovery, process development, analytics, and manufacturing under one roof, we eliminate the friction of fragmented outsourcing and accelerate the path from idea to implementation. This unified approach not only transforms early-stage concepts into viable products but also provides the regulatory alignment and global readiness that today’s biopharma landscape demands.
At Phage Biologics, we believe that every project contributes to the momentum of the entire field. By advancing one program at a time, we collectively expand the boundaries of phage science — unlocking new therapies, new platforms, and new possibilities. This is the power of true phage CDMO partnerships: enabling breakthroughs that matter, supporting innovators at every stage, and shaping the future of biotechnology together.
Phage Biologics. Phage Systems. Precision Innovation. Beyond Viral Boundaries!
Contact our sales team at info@phagebiologics.com